Predicting survival in malignant pleural mesothelioma using routine clinical and laboratory characteristics

Predicting survival in malignant pleural mesothelioma using routine clinical and laboratory characteristics

Introduction The prognosis of malignant pleural mesothelioma (MPM) is poor, with a median survival of 8–12 months. The ability to predict prognosis in MPM would help clinicians to make informed decisions regarding treatment and identify appropriate research opportunities for patients. The aims of th...

Full description

Bibliographic Details
Main Authors: Lesley Bishop, Samal Gunatilake, Laura Marshall, Carole Fogg, David Lodge, Daniel Neville, Thomas Jones, Selina Begum, Sumita Kerley, Sharon Glaysher, Scott Elliott, Rebecca Stores
Format: Article
Language:English
Published: BMJ Publishing Group 2021-08-01
Series:BMJ Open Respiratory Research
Online Access:https://bmjopenrespres.bmj.com/content/8/1/e000506.full

Internet

https://bmjopenrespres.bmj.com/content/8/1/e000506.full

Similar Items